Global Recombinant Human Granulocyte Colony-Stimulating Market Research Report 2024

Recombinant Human Granulocyte Colony-Stimulating Market

Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.

G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.

The global Recombinant Human Granulocyte Colony-Stimulating market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Recombinant Human Granulocyte Colony-Stimulating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant Human Granulocyte Colony-Stimulating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Recombinant Human Granulocyte Colony-Stimulating include Amgen, Qilu Pharmaceutical, Shijiazhuang Pharmaceutical, Kyowa Hakko Kirin, Gensci, Amoytop Biotech, Hangzhou Jiuyuan, Huaxin and Triprime, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Granulocyte Colony-Stimulating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Granulocyte Colony-Stimulating.

Report Scope

The Recombinant Human Granulocyte Colony-Stimulating market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Granulocyte Colony-Stimulating market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Granulocyte Colony-Stimulating manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Amgen

Qilu Pharmaceutical

Shijiazhuang Pharmaceutical

Kyowa Hakko Kirin

Gensci

Amoytop Biotech

Hangzhou Jiuyuan

Huaxin

Triprime

Sinovac

Zhaoke

Kawin

Lenograstim (Granocyte)

Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

Others

Chemotherapy Induced Neutropenia

Before Blood Donation

Stem Cell Transplants

Others

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Scope of Recombinant Human Granulocyte Colony-Stimulating Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Recombinant Human Granulocyte Colony-Stimulating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Recombinant Human Granulocyte Colony-Stimulating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Recombinant Human Granulocyte Colony-Stimulating

1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type

1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Value Comparison by Type (2024-2030)

1.2.2 Lenograstim (Granocyte)

1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

1.2.4 Others

1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application

1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Value by Application: (2024-2030)

1.3.2 Chemotherapy Induced Neutropenia

1.3.3 Before Blood Donation

1.3.4 Stem Cell Transplants

1.3.5 Others

1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts

1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2019-2030

1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2019-2030

1.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2019-2024)

2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Manufacturers (2019-2024)

2.4 Global Recombinant Human Granulocyte Colony-Stimulating Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating, Product Type & Application

2.7 Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation and Trends

2.7.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players Market Share by Revenue

2.7.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Recombinant Human Granulocyte Colony-Stimulating Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region: 2019-2030

3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region: 2019-2024

3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region: 2025-2030

3.3 Global Recombinant Human Granulocyte Colony-Stimulating Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region: 2019-2030

3.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region: 2019-2024

3.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region: 2025-2030

3.4 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country

3.4.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2030)

3.4.3 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country

3.5.1 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2030)

3.5.3 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country

3.6.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2030)

3.6.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country

3.7.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2030)

3.7.3 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2030)

3.8.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2019-2030)

4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2019-2024)

4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2025-2030)

4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2019-2030)

4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2019-2030)

4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2019-2024)

4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2025-2030)

4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2019-2030)

4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2019-2030)

5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2019-2030)

5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2019-2024)

5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2025-2030)

5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2019-2030)

5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2019-2030)

5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2019-2024)

5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2025-2030)

5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2019-2030)

5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2019-2030)

6.1 Amgen

6.1.1 Amgen Corporation Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Qilu Pharmaceutical

6.2.1 Qilu Pharmaceutical Corporation Information

6.2.2 Qilu Pharmaceutical Description and Business Overview

6.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.2.5 Qilu Pharmaceutical Recent Developments/Updates

6.3 Shijiazhuang Pharmaceutical

6.3.1 Shijiazhuang Pharmaceutical Corporation Information

6.3.2 Shijiazhuang Pharmaceutical Description and Business Overview

6.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.3.5 Shijiazhuang Pharmaceutical Recent Developments/Updates

6.4 Kyowa Hakko Kirin

6.4.1 Kyowa Hakko Kirin Corporation Information

6.4.2 Kyowa Hakko Kirin Description and Business Overview

6.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.4.5 Kyowa Hakko Kirin Recent Developments/Updates

6.5 Gensci

6.5.1 Gensci Corporation Information

6.5.2 Gensci Description and Business Overview

6.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.5.5 Gensci Recent Developments/Updates

6.6 Amoytop Biotech

6.6.1 Amoytop Biotech Corporation Information

6.6.2 Amoytop Biotech Description and Business Overview

6.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.6.5 Amoytop Biotech Recent Developments/Updates

6.7 Hangzhou Jiuyuan

6.6.1 Hangzhou Jiuyuan Corporation Information

6.6.2 Hangzhou Jiuyuan Description and Business Overview

6.6.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.7.5 Hangzhou Jiuyuan Recent Developments/Updates

6.8 Huaxin

6.8.1 Huaxin Corporation Information

6.8.2 Huaxin Description and Business Overview

6.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.8.5 Huaxin Recent Developments/Updates

6.9 Triprime

6.9.1 Triprime Corporation Information

6.9.2 Triprime Description and Business Overview

6.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.9.5 Triprime Recent Developments/Updates

6.10 Sinovac

6.10.1 Sinovac Corporation Information

6.10.2 Sinovac Description and Business Overview

6.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.10.5 Sinovac Recent Developments/Updates

6.11 Zhaoke

6.11.1 Zhaoke Corporation Information

6.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview

6.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.11.5 Zhaoke Recent Developments/Updates

6.12 Kawin

6.12.1 Kawin Corporation Information

6.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview

6.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio

6.12.5 Kawin Recent Developments/Updates

7.1 Recombinant Human Granulocyte Colony-Stimulating Industry Chain Analysis

7.2 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Human Granulocyte Colony-Stimulating Production Mode & Process

7.4 Recombinant Human Granulocyte Colony-Stimulating Sales and Marketing

7.4.1 Recombinant Human Granulocyte Colony-Stimulating Sales Channels

7.4.2 Recombinant Human Granulocyte Colony-Stimulating Distributors

7.5 Recombinant Human Granulocyte Colony-Stimulating Customers

8.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends

8.2 Recombinant Human Granulocyte Colony-Stimulating Market Drivers

8.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges

8.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Market Value Comparison by Type (2024-2030) & (US$ Million)

    Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Market Value Comparison by Application (2024-2030) & (US$ Million)

    Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation by Manufacturers in 2023

    Table 4. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) of Key Manufacturers (2019-2024)

    Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2019-2024)

    Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Manufacturers (2019-2024)

    Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2019-2024)

    Table 8. Global Market Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) of Key Manufacturers (2019-2024)

    Table 9. Global Key Players of Recombinant Human Granulocyte Colony-Stimulating, Industry Ranking, 2022 VS 2023 VS 2024

    Table 10. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating, Product Type & Application

    Table 12. Global Key Manufacturers of Recombinant Human Granulocyte Colony-Stimulating, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2023)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2019-2024) & (KG)

    Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2019-2024)

    Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2025-2030) & (KG)

    Table 20. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2025-2030)

    Table 21. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2019-2024) & (US$ Million)

    Table 22. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2019-2024)

    Table 23. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2025-2030) & (US$ Million)

    Table 24. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2025-2030)

    Table 25. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 26. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2024) & (KG)

    Table 27. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2025-2030) & (KG)

    Table 28. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2024) & (US$ Million)

    Table 29. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2025-2030) & (US$ Million)

    Table 30. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 31. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2024) & (KG)

    Table 32. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2025-2030) & (KG)

    Table 33. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2024) & (US$ Million)

    Table 34. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2025-2030) & (US$ Million)

    Table 35. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

    Table 36. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2019-2024) & (KG)

    Table 37. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2025-2030) & (KG)

    Table 38. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2019-2024) & (US$ Million)

    Table 39. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 41. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2024) & (KG)

    Table 42. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2025-2030) & (KG)

    Table 43. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2024) & (US$ Million)

    Table 44. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2025-2030) & (US$ Million)

    Table 45. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

    Table 46. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2019-2024) & (KG)

    Table 47. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2025-2030) & (KG)

    Table 48. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2019-2024) & (US$ Million)

    Table 49. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2025-2030) & (US$ Million)

    Table 50. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Type (2019-2024)

    Table 51. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Type (2025-2030)

    Table 52. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2019-2024)

    Table 53. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2025-2030)

    Table 54. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Type (2019-2024)

    Table 55. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Type (2025-2030)

    Table 56. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2019-2024)

    Table 57. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2025-2030)

    Table 58. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2019-2024)

    Table 59. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2025-2030)

    Table 60. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2019-2024)

    Table 61. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2025-2030)

    Table 62. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2019-2024)

    Table 63. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2025-2030)

    Table 64. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Application (2019-2024)

    Table 65. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Application (2025-2030)

    Table 66. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2019-2024)

    Table 67. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2025-2030)

    Table 68. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2019-2024)

    Table 69. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2025-2030)

    Table 70. Amgen Corporation Information

    Table 71. Amgen Description and Business Overview

    Table 72. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 73. Amgen Recombinant Human Granulocyte Colony-Stimulating Product

    Table 74. Amgen Recent Developments/Updates

    Table 75. Qilu Pharmaceutical Corporation Information

    Table 76. Qilu Pharmaceutical Description and Business Overview

    Table 77. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 78. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product

    Table 79. Qilu Pharmaceutical Recent Developments/Updates

    Table 80. Shijiazhuang Pharmaceutical Corporation Information

    Table 81. Shijiazhuang Pharmaceutical Description and Business Overview

    Table 82. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 83. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product

    Table 84. Shijiazhuang Pharmaceutical Recent Developments/Updates

    Table 85. Kyowa Hakko Kirin Corporation Information

    Table 86. Kyowa Hakko Kirin Description and Business Overview

    Table 87. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 88. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product

    Table 89. Kyowa Hakko Kirin Recent Developments/Updates

    Table 90. Gensci Corporation Information

    Table 91. Gensci Description and Business Overview

    Table 92. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 93. Gensci Recombinant Human Granulocyte Colony-Stimulating Product

    Table 94. Gensci Recent Developments/Updates

    Table 95. Amoytop Biotech Corporation Information

    Table 96. Amoytop Biotech Description and Business Overview

    Table 97. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 98. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product

    Table 99. Amoytop Biotech Recent Developments/Updates

    Table 100. Hangzhou Jiuyuan Corporation Information

    Table 101. Hangzhou Jiuyuan Description and Business Overview

    Table 102. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 103. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product

    Table 104. Hangzhou Jiuyuan Recent Developments/Updates

    Table 105. Huaxin Corporation Information

    Table 106. Huaxin Description and Business Overview

    Table 107. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 108. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product

    Table 109. Huaxin Recent Developments/Updates

    Table 110. Triprime Corporation Information

    Table 111. Triprime Description and Business Overview

    Table 112. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 113. Triprime Recombinant Human Granulocyte Colony-Stimulating Product

    Table 114. Triprime Recent Developments/Updates

    Table 115. Sinovac Corporation Information

    Table 116. Sinovac Description and Business Overview

    Table 117. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 118. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product

    Table 119. Sinovac Recent Developments/Updates

    Table 120. Zhaoke Corporation Information

    Table 121. Zhaoke Description and Business Overview

    Table 122. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 123. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product

    Table 124. Zhaoke Recent Developments/Updates

    Table 125. Kawin Corporation Information

    Table 126. Kawin Description and Business Overview

    Table 127. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

    Table 128. Kawin Recombinant Human Granulocyte Colony-Stimulating Product

    Table 129. Kawin Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Recombinant Human Granulocyte Colony-Stimulating Distributors List

    Table 133. Recombinant Human Granulocyte Colony-Stimulating Customers List

    Table 134. Recombinant Human Granulocyte Colony-Stimulating Market Trends

    Table 135. Recombinant Human Granulocyte Colony-Stimulating Market Drivers

    Table 136. Recombinant Human Granulocyte Colony-Stimulating Market Challenges

    Table 137. Recombinant Human Granulocyte Colony-Stimulating Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Recombinant Human Granulocyte Colony-Stimulating

    Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Market Value Comparison by Type (2024-2030) & (US$ Million)

    Figure 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2023 & 2030

    Figure 4. Lenograstim (Granocyte) Product Picture

    Figure 5. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture

    Figure 6. Others Product Picture

    Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Market Value Comparison by Application (2024-2030) & (US$ Million)

    Figure 8. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2023 & 2030

    Figure 9. Chemotherapy Induced Neutropenia

    Figure 10. Before Blood Donation

    Figure 11. Stem Cell Transplants

    Figure 12. Others

    Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Revenue, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Market Size (2019-2030) & (US$ Million)

    Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales (2019-2030) & (KG)

    Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) & (2019-2030)

    Figure 17. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered

    Figure 18. Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers in 2023

    Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers in 2023

    Figure 20. The Global 5 and 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players: Market Share by Revenue in 2023

    Figure 21. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

    Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Figure 23. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2019-2030)

    Figure 24. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2019-2030)

    Figure 25. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 26. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 27. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2019-2030)

    Figure 28. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2019-2030)

    Figure 29. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 30. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 31. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 32. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 33. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 34. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2019-2030)

    Figure 35. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2019-2030)

    Figure 36. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 37. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 38. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 39. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 40. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 41. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 42. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 43. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 44. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 45. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 46. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2019-2030)

    Figure 47. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2019-2030)

    Figure 48. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 49. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 50. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 51. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2019-2030)

    Figure 52. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2019-2030)

    Figure 53. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 54. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 55. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2019-2030) & (US$ Million)

    Figure 56. Global Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2019-2030)

    Figure 57. Global Revenue Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2019-2030)

    Figure 58. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2019-2030)

    Figure 59. Global Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Application (2019-2030)

    Figure 60. Global Revenue Market Share of Recombinant Human Granulocyte Colony-Stimulating by Application (2019-2030)

    Figure 61. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2019-2030)

    Figure 62. Recombinant Human Granulocyte Colony-Stimulating Value Chain

    Figure 63. Recombinant Human Granulocyte Colony-Stimulating Production Process

    Figure 64. Channels of Distribution (Direct Vs Distribution)

    Figure 65. Distributors Profiles

    Figure 66. Bottom-up and Top-down Approaches for This Report

    Figure 67. Data Triangulation

    Figure 68. Key Executives Interviewed